Desjardins Increases Andean Precious Metals (CVE:APM) Price Target to C$1.70

Andean Precious Metals (CVE:APM) had its price objective lifted by Desjardins from C$1.60 to C$1.70 in a research report report published on Tuesday morning, BayStreet.CA reports. Desjardins currently has a buy rating on the stock. Desjardins also issued estimates for Andean Precious Metals’ FY2024 earnings at $0.20 EPS and FY2025 earnings at $0.38 EPS.

Andean Precious Metals Stock Down 4.0 %

Shares of APM opened at C$0.96 on Tuesday. The stock has a market cap of C$143.39 million, a price-to-earnings ratio of 2.53 and a beta of 1.14. The business has a fifty day moving average price of C$1.02. Andean Precious Metals has a twelve month low of C$0.53 and a twelve month high of C$1.11.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.